About ATNM

Actinium Pharmaceuticals, Inc. is a New York, NY based biopharmaceutical company that develops innovative alpha particle immunotherapeutics based on its proprietary platform for the therapeutic utilization of alpha particle emitting actinium-225 and bismuth-213 radiopharmaceuticals in association with monoclonal antibodies.
Primary Exchange: AMEX
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ATNM is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ITOT iShares Core S&P Total U.S. Stock Market ETF 19.6 B 1.96269E+10 3,548 3548 0.0% 0 11 K 10782
VTI Vanguard Total Stock Market ETF 109.6 B 1.096E+11 3,588 3588 0.0% 0 233 K 232664
VXF Vanguard Extended Market ETF 6.8 B 6.8E+09 3,242 3242 0.0% 1E-05 47 K 47159